Document Detail


Investigation of SERPINE1 genetic polymorphism in Macedonian patients with occlusive artery disease and deep vein thrombosis.
MedLine Citation:
PMID:  20017074     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Raised SERPINE1 plasma levels are related to a 1-bp guanine deletion/insertion (4G5G) polymorphism in the promoter of the SERPINE1 (plasminogen activator inhibitor 1 - PAI1) gene. Evidence suggested that the plasma levels of SERPINE1 modulate the risk of coronary artery disease; furthermore, that the 4G5G polymorphism affects the expression of the SERPINE1 gene. AIM: To analyse association of SERPINE1 polymorphism with occlusive artery disease (OAD) and deep venous thrombosis (DVT) in Macedonians in order to investigate its role as a part of candidate genes in different vascular diseases in Macedonians. METHODS: Investigated groups consisted of 82 healthy patients, 75 with OAD, and 66 with DVT. Blood samples were collected after written informed consent was obtained, and DNA was isolated from peripheral blood leukocytes. Identification of SERPINE1 polymorphism was done with CVD StripAssay (ViennaLab, Labordiagnostica GmbH, Austria). The population genetics analysis package, PyPop, was used for analysis of the SERPINE1 data. Pearson's P-values, crude odds ratio and Wald's 95% CI were calculated with Bonferroni corrected p value. RESULTS: The frequency of 4G allele for SERPINE1 was 0.538 for DVT, 0.555 for healthy participants, and 0.607 for OAD. The frequency of 5G allele for SERPINE1 was the smallest in patients with OAD (0.393) and was higher in healthy participants (0.445), and patients with DVT (0.462). Test of neutrality (Fnd) showed negative value, but was significantly different from 0 for SERPINE1 in healthy participants (p of F = 0.041) and in patients with DVT (p of F = 0.030). SERPINE1 genotypes in healthy participants and patients with OAD were not in Hardy Weinberg proportions (p = 0.019 and 0.001, respectively). No association between SERPINE1 polymorphisms and OAD or DVT was found. CONCLUSION: There is no significant relationship between SERPINE1 polymorphisms and occlusive artery disease or deep venous thrombosis in Macedonian population.
Authors:
Igor Spiroski; Sashko Kedev; Slobodan Antov; Dejan Trajkov; Aleksandar Petlichkovski; Sloboda Dzhekova-Stojkova; Stojanka Kostovska; Mirko Spiroski
Related Documents :
16926524 - Associations between two single nucleotide polymorphisms of adiponectin gene and corona...
15186954 - Functional effects of nad(p)h oxidase p22(phox) c242t mutation in human leukocytes and ...
16210494 - Critical investigation of the cd14 promoter polymorphism: lack of a role for in vitro c...
15142214 - Lack of association between the tnf alpha g -308 a promoter polymorphism and periodonta...
7930674 - Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in huma...
20646304 - Fleece variation in alpaca (vicugna pacos): a two-locus model for the suri/huacaya phen...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Kardiologia polska     Volume:  67     ISSN:  0022-9032     ISO Abbreviation:  Kardiol Pol     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-12-17     Completed Date:  2010-04-09     Revised Date:  2010-04-19    
Medline Journal Info:
Nlm Unique ID:  0376352     Medline TA:  Kardiol Pol     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  1088-94     Citation Subset:  IM    
Affiliation:
Clinic of Cardiology, Faculty of Medicine, Ss. Cyril and Methodius University, Blvd. Krste Petkov Misirkov bb, 1000 Skopje, Republic of Macedonia. ispiroski@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Arterial Occlusive Diseases / genetics*
Case-Control Studies
European Continental Ancestry Group / genetics
Female
Gene Frequency / genetics
Humans
Macedonia (Republic)
Male
Middle Aged
Plasminogen Activator Inhibitor 1 / genetics*
Polymorphism, Genetic / genetics*
Polymorphism, Single Nucleotide
Risk Factors
Venous Thrombosis / genetics*
Chemical
Reg. No./Substance:
0/Plasminogen Activator Inhibitor 1; 0/SERPINE1 protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quality of life in young, professionally active men undergoing on-pump coronary artery bypass grafti...
Next Document:  Analysis of 12-lead electrocardiogram in top competitive professional athletes in the light of recen...